Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Recruiting now · Not applicable

Conditions studied: Carcinoma, Hepatocellular, Cirrhosis

In brief

The study is a randomized trial of two different screening methods for early detection of liver cancer in patients with cirrhosis of the liver. The goal of PREMIUM is to compare an abbreviated version of the diagnostic gold standard for HCC (aMRI) +AFP to the standard-of-care screening (US+AFP) in patients at high risk of developing HCC. The investigators hypothesize that HCC will be detected at earlier stages, allowing for more curative treatments and resulting in a reduction in HCC-related mortality.

Key facts

Study ID
NCT05486572
Run by
VA Office of Research and Development
People needed
4700
Starts
2023-11-03
Expected to finish
2031-09-01
Last updated by the study team
2026-06-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.